Subsequent functional assays, including colony formation, CCK-8, and EdU assays, consistently demonstrated that silencing ZFHX4-AS1 inhibited glioma cell proliferation, whereas its overexpression significantly promoted proliferation (Figures 2F–H). Here, ZFHX4 is linked to central nervous system cancer.